MSACL 2025
Welcome to MSACL 2025
Are you looking to stay at the forefront of clinical research? MSACL 2025 is the event for you! The Bruker team is inviting you to join us in Montreal from September 21 - 26 to discover how our partnership with RECIPE, PinPoint Testing and biocrates can help you unlock efficiency in your lab.
Visit our booth No. 24 to see the EVOQ® DART-TQ+ and our full kit solutions for yourself, join our poster presentations and catch up with our team to learn about our innovative chromatography-free methods coupled with mass spectrometry and see where we're heading next.
What to look forward to:
- Get a firsthand look at our latest innovations: Learn about our innovative EVOQ® DART-TQ+ and the new ClinDART® platform for clinical research applications and discover novel approaches to chromatography-free mass spectrometry, sample preparation, data analysis, and quality control.
- Learn more about chromatography-free workflows: Chromatography-free techniques can speed up analysis time from minutes to seconds while also eliminating 95 percent of organic waste - find out how your lab can benefit from chromatography-free workflows.
- Meet the team: Come by our booth and have a chat with our experts to discuss how we can solve your analytical challenges and find tailored solutions.
We look forward to meeting you in Montreal and discussing how our products and services can support your analytical needs.
MSACL 2025 Montreal
September 21-26, 2025
Bonaventure Hotel Conference Center
Montreal, Canada
If you want to learn more about our solutions or schedule a meeting at the MSACL with our team, please each out via email:
Poster Presentations
Wednesday, September 24, at 09:15–10:30h in the Exhibit Hall
- Evaluation of a Fast Dart-MS Oral Fluid Method as a Potential Toxicology Screening Workflow
- Francois Espourteille, Bruker Applied Mass Spectrometry
- Poster #47a View Map
Thursday, September 25, at 12:15-13:30 h in the Exhibit Hall:
- Development and Validation of Method for Quantification of Antimycotics utilizing DART-MS
- Lukas Brunner, RECIPE Chemicals + Instruments GmbH
- Poster #48c View Map
- A Chromatography-free MS Method for the Ultrafast Quantification of Various Therapeutic Agents by DART-MS/MS for Research Purposes
- Zahuindanda Aventura, Bruker Applied Mass Spectrometry
- Poster #46c View Map
- Quantitative, Large Panel Metabolomics and Lipidomics with the MxP® Quant 1000 Kit Optimized and Validated for the Bruker EVOQ® TQ Mass Spectrometer
- Sebastian Gottfried, biocrates life sciences ag
- Poster #47c View Map
Also, don’t miss Julie Ray from ARUP presenting a Proof-of-Concept Study on measuring antifungals in human serum using Direct Analysis in Real Time-Mass Spectrometry (DART-MS). Join us for this exciting oral session in Track 5 (Montreal 6–8) on Thursday, September 26, at 16:05 and discover how cutting-edge technology is transforming clinical research:
- A Proof-of Concept Study: Measuring Antifungals in Human Serum Using Direct Analysis in Real Time-Mass Spectrometry (DART-MS)
- Julie Ray, ARUP
- Oral in Track 5 (Montreal 6-8)
- Thursday, September 26, at 16:05 pm
Clinical Research Elevated: Bruker and RECIPE Launch Verified Assay Integration
Bruker and RECIPE are advancing clinical research through the integration of RECIPE’s ClinMass® and ClinDART® assay kits with Bruker’s EVOQ® DART-TQ⁺ system. This collaboration enables high-throughput workflows for clinical research applications.
ClinMass® kits are now suitable for use on the EVOQ® DART-TQ+ system, while we prepare to introduce our novel ClinDART® assays soon for chromatography-free, rapid analysis with significant reductions in cost, waste, and complexity. Together, these innovations will support more efficient, scalable, and accessible clinical research, with key results to be showcased at MSACL in Montreal.
Forensic Innovation Unlocked: Bruker and PinPoint Redefine Toxicology Workflows
Bruker’s collaboration with PinPoint Testing is transforming forensic toxicology (non-clinical) through innovative, chromatography-free mass spectrometry workflows. Bruker’s advanced instrumentation paired with PinPoint’s validated methods and expert consulting deliver turnkey solutions for forensic labs.
Together, they offer rapid, chromatography-free screening and confirmation of drugs of abuse, controlled substances, and emerging illicit compounds using platforms like the ToxBox® and DART-MS/MS. This synergy allows forensic laboratories to streamline operations and reduce sample backlogs.
Advancing Metabolomics Research: Bruker and biocrates Accelerate Clinical Research with Triple Quad Assay
Bruker Applied Mass Spectrometry and biocrates have partnered to bring advanced metabolomics capabilities to clinical research through the MxP® Quant 1000 kit, now method-verified on the Bruker EVOQ® DART-TQ+ mass spectrometer.
By combining biocrates’ modular, quality-controlled kits with Bruker’s robust triple quadrupole platform, researchers can confidently explore quantitative metabolomics panels with high reproducibility and coverage. The collaboration will be showcased at MSACL, where attendees can learn how this integrated workflow supports translational research and clinical research assay development.
For Research Use Only. Not for Use in Clinical Diagnostic Procedures.